These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2279536)

  • 1. Influence of flavonoids and lanthanides on kappa-carrageenin rat tail thrombosis.
    Bekemeier H; Gabor M; Hirschelmann R
    Exp Pathol; 1990; 40(1):61-3. PubMed ID: 2279536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of eicosanoids in the kappa-carrageenin rat tail thrombosis.
    Bekemeier H; Hirschelmann R
    Biomed Biochim Acta; 1988; 47(10-11):S260-3. PubMed ID: 2470355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new low molecular weight heparan sulphate antagonizes kappa-carrageenan-induced thrombosis in rats.
    Gervasi GB; Bartoli C; Carpita G
    Pharmacol Res; 1991 Jul; 24(1):59-63. PubMed ID: 1658763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiaggregatory effects of flavonoids in vivo and their influence on lipoxygenase and cyclooxygenase in vitro.
    Swies J; Robak J; Dabrowski L; Duniec Z; Michalska Z; Gryglewski RJ
    Pol J Pharmacol Pharm; 1984; 36(5):455-63. PubMed ID: 6442773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrageenin-induced thrombosis in the rat and mouse as a test model of substances influencing thrombosis.
    Bekemeier H; Hirschelmann R; Giessler AJ
    Biomed Biochim Acta; 1984; 43(8-9):S347-50. PubMed ID: 6517902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human myeloperoxidase activity is inhibited in vitro by quercetin. Comparison with three related compounds.
    Pincemail J; Deby C; Thirion A; de Bruyn-Dister M; Goutier R
    Experientia; 1988 May; 44(5):450-3. PubMed ID: 2836234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrageenin-induced thrombosis in rats and mice: a model for testing antithrombotic substances?
    Bekemeier H; Hirschelmann R; Giessler AJ
    Agents Actions; 1985 Jul; 16(5):446-51. PubMed ID: 4050621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis (infarction) induced by kappa-carrageenin in rat tail: inhibition during adjuvant arthritis.
    Hirschelmann R; Bekemeier H
    Exp Pathol; 1987; 31(3):175-8. PubMed ID: 3609241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin and phenprocoumon inhibit kappa-carrageenin induced thrombosis in rats.
    Hirschelmann R; Bekemeier H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):379-82. PubMed ID: 2428713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of aldose reductase inhibitors on the metabolism of cultured monkey kidney epithelial cells.
    Boot-Handford R; Heath H
    Biochem Pharmacol; 1981 Nov; 30(22):3065-9. PubMed ID: 6802136
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo evaluation method of the effect of nattokinase on carrageenan-induced tail thrombosis in a rat model.
    Kamiya S; Hagimori M; Ogasawara M; Arakawa M
    Acta Haematol; 2010; 124(4):218-24. PubMed ID: 21071931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of serotonin, serotonin antagonists, some vasoactive substances and temperature on carrageenin-induced tail thrombosis in rats and mice.
    Bekemeier H; Hirschelmann R
    Agents Actions; 1986 Aug; 18(5-6):581-5. PubMed ID: 3766313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavonoid mixture (diosmin, troxerutin, rutin, hesperidin, quercetin) in the treatment of I-III degree hemorroidal disease: a double-blind multicenter prospective comparative study.
    Corsale I; Carrieri P; Martellucci J; Piccolomini A; Verre L; Rigutini M; Panicucci S
    Int J Colorectal Dis; 2018 Nov; 33(11):1595-1600. PubMed ID: 29934701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monohydroxyethylrutoside, a dose-dependent cardioprotective agent, does not affect the antitumor activity of doxorubicin.
    van Acker SA; Boven E; Kuiper K; van den Berg DJ; Grimbergen JA; Kramer K; Bast A; van der Vijgh WJ
    Clin Cancer Res; 1997 Oct; 3(10):1747-54. PubMed ID: 9815559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving frequency of thrombosis by altering blood flow in the carrageenan-induced rat tail thrombosis model.
    Hagimori M; Kamiya S; Yamaguchi Y; Arakawa M
    Pharmacol Res; 2009 Oct; 60(4):320-3. PubMed ID: 19394423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of propionyl carnitine in vascular disorders experimentally induced by endothelin (ET-1) serotonin and K-carrageenin.
    Bertelli A; Giovannini L; Galmozzi G; Bertelli AA
    Drugs Exp Clin Res; 1993; 19(1):7-11. PubMed ID: 8223141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 0-/-B-hydroxyethyl/rutoside on platelet function and thrombus formation in rat mesenteric vessels.
    Krupiński K; Breddin HK; Giedrojć J; Bodzenta-Lukaszyk A; Bielawiec M
    Mater Med Pol; 1995; 27(2):39-42. PubMed ID: 8935187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hydroxyethyl rutosides and related compounds on lipid peroxidation and free radical scavenging activity. Some structural aspects.
    Rekka E; Kourounakis PN
    J Pharm Pharmacol; 1991 Jul; 43(7):486-91. PubMed ID: 1682461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potentiating effect of propionyl carnitine on prostacycline prevention of thrombosis induced by endothelin (ET-1) and K-carrageenin.
    Bertelli A; Bertelli AA; Giovannini L
    Drugs Exp Clin Res; 1994; 20(1):7-11. PubMed ID: 7924894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Venoruton on the factor XIII activity in rat plasma.
    Grochal M; Sempińska-Edelberg E; Plewiński J
    Pol J Pharmacol Pharm; 1978; 30(5):659-63. PubMed ID: 751007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.